-+ 0.00%
-+ 0.00%
-+ 0.00%

EDESA BIOTECH GRANTED ORPHAN DESIGNATION FOR PARIDIPRUBART FOR THE TREATMENT OF ARDS BY THE EUROPEAN COMMISSION

Reuters·11/17/2026 14:25:00

Please log in to view news